Pharmacoepidemiology and Drug Safety
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Lithium toxicity following co-prescription of lithium and angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs)
2023
-
Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study
2022
-
Treatment effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people underrepresented from the ontarget trial: Analysis of routinely collected data using trial replication methods
2022
-
A decision aid to drive adherence to controller treatments in mild asthma: A rapid-cycle design study
2021
-
Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study
2021
-
Head to head comparisons of therapies using real world data: What is needed to emulate target trials?
2020
-
Real-world cost-effectiveness of direct oral anticoagulants in the Quebec setting
2020
-
Data variability across Canadian administrative health databases: Differences in content, coding, and completeness
2020
-
A simulation-based comparison of confounding adjustment methods in observational studies of administrative data
2019
-
Misoprostol as an adjunct to oxytocin can reduce postpartum hemorrhage among pregnant women delivering in Bamenda Cameroon, 2015-2016: a propensity score-matched retrospective chart review
2019
-
The devil you should know: Adjustment for confounding bias is rare in observational economic evaluations in cardiology
2019
-
Use of Oral Fluconazole during Pregnancy and Risks of Spontaneous Abortion, Stillbirth and Major Congenital Malformation: An International, Multi-Centre Cohort Study
2019
-
Identification of incident pancreatic cancer in administrative health data: A validation study by the Canadian Network for Observational Drug Effect Studies (CNODES)
2018
-
Real-world use of dulaglutide in Europe: A multi-country drug utilization study
2018
-
Use of Attention Deficit Hyperactivity Disorder Medication Amongst Adults in Quebec, Canada
2017
-
Real-World Effectiveness of Omalizumab for the Treatment of Severe Asthma
2016
-
Trends in Oral Glucocorticoid Utilization Among Older Adults with Respiratory Disease
2016
-
Association between Genetic Polymorphisms of Drug-metabolizing Enzymes and Transporters and Anti-tuberculosis Drug-induced Liver Injury in a Chinese Population
2015
-
Beta Blockers and the Risk of Suicide in the Elderly
2015
-
Efficacy of Osteoporosis Pharmacotherapies in Preventing Fractures among Chronic Oral Glucocorticoids Users: A Network Meta-analysis
2015
-
Lipophilic Statins and the Risk of Suicide: A Population-based Study
2015
-
Predictors of Ontario's Medication Review Program (MedsCheck Annual Service) Utilization Among Ontario Seniors
2015
-
Psychiatric Healthcare Utilization and Related Costs in Newly Diagnosed Individuals with Autism Spectrum Disorder (ASD) in Quebec (Canada)
2015
-
women’s Values and Preferences: Decision Making about Thromboprophylaxis in Pregnancy: 445.
2015
-
Adverse Reactions Associated To Biologics for Psoriasis in Brazil
2014
-
Follow-Up of Psychoactive Drug Use in Newly Diagnosed Patients with Autism Spectrum Disorder (ASD) in Quebec (Canada)
2014
-
Incretin Therapy and Risk of Pancreatitis in Type 2 Diabetes Mellitus: Systematic Review of Randomized and Non-Randomized Studies
2014
-
Psychiatric Health Care Utilisation and Related Costs in Newly Diagnosed Patients with Autism Spectrum Disorder (ASD) in Quebec (Canada)
2014
-
Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes Mellitus: A Pairwise and Network Meta-Analysis
2013
-
Potential for Selection Bias in the Context of a Restriction Drug Access Program: The Case of Atomoxetine in Quebec, Canada
2013
-
Beware of Policy-Induced Selection Bias in Drug Effect Studies: Example in the Comparative Effectiveness of Oral Bisphosphonates
2012
-
Direct Cost of Schizophrenia in Quebec, Canada: An Incidence-Based Microsimulation Monte-Carlo Markov Model
2011
-
Factors Associated with the Schizophrenia Specific States: A Population-Based Study
2010
-
Validation of a Monte-Carlo Markov Model for Schizophrenia
2010
-
A method for estimating the completeness of a literature search
2008
-
An exploration of methodologies to individualize and integrate warfarin's benefit and harm
2008
-
Concomitant use of cardiovascular related medications in diabetic patients receiving rosiglitazone
2008
-
Consent for use of health information (HI) for research: Comparison of patient and general public attitudes
2008
-
Evaluation of pharmacoepidemiology trials: Rigour methodologica versus rigor mortis
2008
-
Causality assessment of adverse events in oncology clinical trials: A qualitative study
2007
-
Community-based global cardiovascular risk reduction with pharmacotherapy for modifiable risk factors in high-risk patients
2007
-
Development and validation of an adverse event causality assessment tool for use in oncology clinical trials
2007
-
Orthogonal experimental designs disentangle confounding in database studies
2007
-
Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis
2007
-
Enhancing signal detection for pharmacovigilance using pharmacogenomics
2006
-
Is statin therapy associated with a decreased risk for bleeding in patients with chronic atrial fibrillation who are receiving warfarin? A population-based nested case-control study
2006
-
Making a curriculum vita numerical and graphical for tenure, promotion and career awards
2006
-
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark..
33:e5849.
2024
-
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke.
31:1182-1189.
2022
-
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.
31:424-433.
2022
-
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes.
30:379-389.
2021
-
Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada.
28:726-733.
2019
-
Trends and uptake of new formulations of controlled‐release oxycodone in Canada.
27:520-525.
2018
-
Risk of rhabdomyolysis from 5‐α reductase inhibitors.
27:351-355.
2018
-
Comparison of the ability of double‐robust estimators to correct bias in propensity score matching analysis. A Monte Carlo simulation study.
26:1513-1519.
2017
-
Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016.
26:1534-1539.
2017
-
Pregabalin and heart failure: A population‐based study.
26:1087-1092.
2017
-
Changes in clinical outcomes for community-dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009.
25:204-211.
2016
-
Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data.
24:67-74.
2015
-
Drug–drug interactions in a cohort of hospitalized elderly patients.
22:1054-1060.
2013
-
A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data.
21:265-273.
2012
-
Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada.
20:1246-1252.
2011
-
Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis.
20:838-848.
2011
-
Concordance between discharge prescriptions and insurance claims in post‐myocardial infarction patients.
16:207-215.
2007
-
Anti-infectives-induced adverse drug reactions in hospitalized patients.
14:501-506.
2005
-
Understanding drug–herb interactions.
12:427-430.
2003
-
The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases.
10:497-508.
2001
-
Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy.
9:367-370.
2000
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)